- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02041572
Attentional Bias Retraining in Veterans (ABR)
October 31, 2017 updated by: VA Pacific Islands Health Care System
The study has two goals.
First to develop a computer-based intervention meant to alter cognitive biases that contribute to ongoing PTSD symptoms.
Second, we sought to pilot test the intervention in a small sample of veterans for feasibility and acceptability.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Aim 1: Develop Attentional Bias Retraining protocol (Phase 1)
- 1.1 Computerized assessment & retraining programs
- 1.2 Procedures and measures
Aim 2: Implement in pilot sample (Phase 2)
- 2.1: Assess feasibility and tolerability
- 2.2: Collect pilot data to plan future studies
- 2.3: Efficacy estimates based on changes in response time to dot probe task
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96819
- National Center for PTSD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 89 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Participated in ground combat operations in Vietnam
- Scored 40 - 80 on PTSD Checklist - Military version
- Availability and willingness to attend 2x weekly computer sessions for 6 weeks
Exclusion Criteria:
- Active substance dependence
- Significant cognitive impairment
- Current and active suicidal or homicidal ideation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: Attentional Bias Retraining
Each participant receives 12 sessions.
The first three sessions are baseline (assessment only) sessions.
The last four sessions must be treatment sessions.
The attentional bias intervention starts randomly on sessions 4 - 8, and continues until the end of the 12 sessions.
|
Participants complete a computer-based intervention, which is designed to correct cognitive biases associated with PTSD by training to attend to neutral information rather than the trauma-related cue words.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-traumatic Checklist - Military version (PCL-M)
Time Frame: Change from Baseline and Post-treatment (1 month after last training session)
|
PCL-M assess the 17-cardinal symptoms of PTSD.
|
Change from Baseline and Post-treatment (1 month after last training session)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attentional bias scores
Time Frame: Change from Baseline and Post-treatment (1 month after last training session)
|
Attentional bias scores represent participants cognitive bias to orient towards trauma-relevant information more quickly than neutral information.
|
Change from Baseline and Post-treatment (1 month after last training session)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily of PTSD symptoms, specifically hyperarousal and intrusive symptoms (nightmares, reenactments, and triggered and untriggered recall)
Time Frame: Change from Baseline and Post-treatment (1 month after last training session)
|
Participants filled out daily symptom log nightly
|
Change from Baseline and Post-treatment (1 month after last training session)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Margaret-Anne Mackintosh, PhD, National Center for PTSD/PHREI
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (ACTUAL)
December 1, 2012
Study Completion (ACTUAL)
June 1, 2015
Study Registration Dates
First Submitted
January 15, 2014
First Submitted That Met QC Criteria
January 17, 2014
First Posted (ESTIMATE)
January 22, 2014
Study Record Updates
Last Update Posted (ACTUAL)
November 6, 2017
Last Update Submitted That Met QC Criteria
October 31, 2017
Last Verified
January 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012-05/MM/PROMISE 0001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
There is no plan to share individual participant data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.